Mesoblast (ASX:MSB), Ziopharm Oncology and Intrexon have teamed up to develop a new class of cell-based cancer treatments, with an initial focus on lung cancer. [ + ]

The outcomes of the NHMRC 2013 grant round have been announced. [ + ]

Allied Healthcare (ASX:AHZ) has raised $10.4m in a rights issue to help fund commercialisation efforts for its CardioCel heart patch. [ + ]

To better understand the export behaviour of Australian companies and help shape Australia's future trade agenda, the Australian Export Council is conducting Australia's International Business Survey. [ + ]

Imugene (ASX:IMU) has agreed to buy Biolife Science, the cancer immunotherapy company that called off a backdoor ASX listing and capital raising earlier this year. [ + ]

Immuron (ASX:IMC) has secured a US patent covering products developed with its colostrum platform technology, as it progresses with talks to bring Travelan to the US. [ + ]

Brisbane will welcome more than 1000 of the brightest brains in biotechnology and innovation next week for the official launch of the AusBiotech 2013 national conference; a premier event on the Australian and Asia-Pacific calendar. [ + ]

Life sciences investment event AusBiotech Invest Conference will take place from 28-29 October at the Melbourne Convention and Exhibition Centre. [ + ]

One of the basic concepts in quantum mechanics is that it is impossible to observe physical objects without affecting them in a significant way; there can be no measurement without disturbance. In 1927, theoretical physicist Werner Heisenberg claimed that this fact could be expressed as an uncertainty relation, describing a reciprocal relation between the accuracy in position and the disturbance in momentum. [ + ]

Trajan has made a number of key appointments to its leadership team. [ + ]

The first Telethon-Perth Children's Hospital Research Fund has provided the impetus for 17 projects. [ + ]

Visualising the structures of complex molecules is now a whole lot easier with a new toolkit. [ + ]

Wealth as a gift for the University of Western Australia. [ + ]

The 20 subjects enrolled in a trial of the HSV-2 vaccine under development at Allied Healthcare's (ASX:AHZ) Coridon have all received two out of three planned doses. [ + ]

Genea Biocells has produced human skeletal muscle from stem cells, in a breakthrough technique with potential applications in the treatment of muscular dystrophies. [ + ]